Example: Heart Attack

Clinical Trials Sponsored by Getz Pharma

Total 9 results

    • NCT04665284
      Completed
      Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus
      Conditions: Type II Diabetes Mellitus
    • NCT04664894
      Completed
      Direct Acting Anti-Viral's In Chronic HCV Patients
      Conditions: Safety Issues
    • NCT04301219
      Completed
      Knowledge and Practices of ADR Reporting in LMICs
      Conditions: Adverse Reaction
    • NCT03710057
      Completed
      Effect of Ivabradine in Lowering Heart Rate and Quality of Life in Chronic Heart Failure Patients
      Conditions: Chronic Heart Failure
    • NCT02601976
      Completed
      Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population
      Conditions: Hepatitis C
    • NCT02600780
      Completed
      Zurig (Febuxostat) 40mg Efficacy and Safety Trial
      Conditions: Hyperuricemia
    • NCT01770483
      Completed
      The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients
      Conditions: Hepatitis C, Chronic; DIABETES MELLITUS Type 2
    • NCT00502970
      Completed
      Short Course of Interferon Treatment in Patients With HCV Infection
      Conditions: Hepatitis C; Chronic Disease; Treatment
    • NCT00415961
      Terminated
      Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety
      Conditions: Coronary Disease
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations